Skip to content

Clinical trials

Observational Ovarian Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Observational Clear all

604 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20015
20028
20039
20045
20058
200619
200718
200812
200916
201015
201119
201218
201322
201414
201525
201632
201725
201820
201924
202029
202141
202252
202329
202451
202535
202627

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed235
Unknown status150
Recruiting117
Not yet recruiting36
Terminated27
Active, not recruiting22
Withdrawn11
Suspended3
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione Policlinico Universitario Agostino Gemelli IRCCS22
AstraZeneca18
M.D. Anderson Cancer Center17
Memorial Sloan Kettering Cancer Center16
National Cancer Institute (NCI)16
Gynecologic Oncology Group12
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University11
National Taiwan University Hospital8
Assiut University6
Royal Marsden NHS Foundation Trust6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms604
Breast Neoplasms110
Endometrial Neoplasms79
Uterine Cervical Neoplasms73
Fallopian Tube Neoplasms68
Lung Neoplasms54
Neoplasms53
Colorectal Neoplasms50
Pancreatic Neoplasms50
Carcinoma, Ovarian Epithelial42

Trials

Showing 51 to 75 of 604. Each trial links to its page on Pharma Observatory.

504 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.